Impact Biomedical Inc. balance sheet

At the end of fiscal 2025, Impact Biomedical Inc. had total assets of $17.4m, total liabilities of $1.9m and shareholders' equity of $12.3m. It held $3,000 in cash against $0 of debt: net cash of $3,000.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Impact Biomedical Inc.: balance sheet, annual
Fiscal year	2022Dec 2022	2025Dec 2025	LTMJun 2026
Cash and equivalents	0	0	—
Receivables	—	0	—
Inventory	—	0	0
Total current assets	0	0	0
Goodwill	25	—	—
Total assets	46	17	17
Accounts payable	1	0	0
Total current liabilities	11	1	2
Total debt	10	0	0
Total liabilities	14	2	3
Shareholders' equity	30	12	11
Non-controlling interests and other (assets − liabilities − equity)	3	3	3
Net debt (negative = net cash)	10	−0	—
Shares outstanding	70m	—	108m

US$ millions unless shown otherwise. Fiscal quarters.

Impact Biomedical Inc.: balance sheet, quarterly
Quarter	2022 Q2Jun 2022	2022 Q3Sept 2022	2022 Q4Dec 2022	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	—	—	—	0	0	0	—	—
Inventory	—	—	—	0	0	0	0	0
Total current assets	—	—	0	1	1	0	0	0
Goodwill	—	—	25	—	—	—	—	—
Total assets	—	—	46	19	18	17	17	17
Accounts payable	—	—	1	1	1	0	0	0
Total current liabilities	—	—	11	23	24	1	2	2
Total liabilities	—	—	14	26	27	2	2	3
Shareholders' equity	38	36	30	−10	−12	12	11	11
Non-controlling interests and other (assets − liabilities − equity)	—	—	3	3	3	3	3	3
Shares outstanding	—	—	70m	12m	12m	105m	108m	108m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: IBO vs LYEL AIM vs IBO IBIO vs IBO

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Impact Biomedical Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Impact Biomedical Inc.